カテゴリー： QYResearch, 世界

世界の動脈血栓症薬市場 2019年

【英語タイトル】Global Arterial Thrombosis Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X03729）・商品コード：DATA909X03729
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、動脈血栓症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他に、用途別には、クリニック、病院、その他にセグメント区分し、動脈血栓症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・動脈血栓症薬の世界市場概要
・動脈血栓症薬の製造コスト構成分析
・動脈血栓症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・動脈血栓症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・動脈血栓症薬のセグメント分析（種類別）
（AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他）
・動脈血栓症薬のセグメント分析（用途別）
（クリニック、病院、その他）
・動脈血栓症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Astellas Pharma Inc.、Bayer AG、Bristol-Myers Squibb Company、Eisai、Johnson & Johnson、Sanofi、Thromboserin Ltd、）
・動脈血栓症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Arterial Thrombosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Arterial Thrombosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Arterial Thrombosis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Arterial Thrombosis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Arterial Thrombosis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Astellas Pharma Inc.
Bayer AG
Bristol-Myers Squibb Company
Eisai
Johnson & Johnson
Sanofi
Thromboserin Ltd
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
AS-1468240
ASP-6537
BAY-1213790
BMS-65445
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Arterial Thrombosis Drug
1.1 Definition of Arterial Thrombosis Drug
1.2 Arterial Thrombosis Drug Segment by Type
1.2.1 Global Arterial Thrombosis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 AS-1468240
1.2.3 ASP-6537
1.2.4 BAY-1213790
1.2.5 BMS-65445
1.2.6 Others
1.3 Arterial Thrombosis Drug Segment by Applications
1.3.1 Global Arterial Thrombosis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Arterial Thrombosis Drug Overall Market
1.4.1 Global Arterial Thrombosis Drug Revenue (2014-2025)
1.4.2 Global Arterial Thrombosis Drug Production (2014-2025)
1.4.3 North America Arterial Thrombosis Drug Status and Prospect (2014-2025)
1.4.4 Europe Arterial Thrombosis Drug Status and Prospect (2014-2025)
1.4.5 China Arterial Thrombosis Drug Status and Prospect (2014-2025)
1.4.6 Japan Arterial Thrombosis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Arterial Thrombosis Drug Status and Prospect (2014-2025)
1.4.8 India Arterial Thrombosis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Arterial Thrombosis Drug
2.3 Manufacturing Process Analysis of Arterial Thrombosis Drug
2.4 Industry Chain Structure of Arterial Thrombosis Drug

3 Development and Manufacturing Plants Analysis of Arterial Thrombosis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Arterial Thrombosis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Arterial Thrombosis Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Arterial Thrombosis Drug Production and Capacity Analysis
4.2 Arterial Thrombosis Drug Revenue Analysis
4.3 Arterial Thrombosis Drug Price Analysis
4.4 Market Concentration Degree

5 Arterial Thrombosis Drug Regional Market Analysis
5.1 Arterial Thrombosis Drug Production by Regions
5.1.1 Global Arterial Thrombosis Drug Production by Regions
5.1.2 Global Arterial Thrombosis Drug Revenue by Regions
5.2 Arterial Thrombosis Drug Consumption by Regions
5.3 North America Arterial Thrombosis Drug Market Analysis
5.3.1 North America Arterial Thrombosis Drug Production
5.3.2 North America Arterial Thrombosis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Arterial Thrombosis Drug Import and Export
5.4 Europe Arterial Thrombosis Drug Market Analysis
5.4.1 Europe Arterial Thrombosis Drug Production
5.4.2 Europe Arterial Thrombosis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Arterial Thrombosis Drug Import and Export
5.5 China Arterial Thrombosis Drug Market Analysis
5.5.1 China Arterial Thrombosis Drug Production
5.5.2 China Arterial Thrombosis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Arterial Thrombosis Drug Import and Export
5.6 Japan Arterial Thrombosis Drug Market Analysis
5.6.1 Japan Arterial Thrombosis Drug Production
5.6.2 Japan Arterial Thrombosis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Arterial Thrombosis Drug Import and Export
5.7 Southeast Asia Arterial Thrombosis Drug Market Analysis
5.7.1 Southeast Asia Arterial Thrombosis Drug Production
5.7.2 Southeast Asia Arterial Thrombosis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Arterial Thrombosis Drug Import and Export
5.8 India Arterial Thrombosis Drug Market Analysis
5.8.1 India Arterial Thrombosis Drug Production
5.8.2 India Arterial Thrombosis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Arterial Thrombosis Drug Import and Export

6 Arterial Thrombosis Drug Segment Market Analysis (by Type)
6.1 Global Arterial Thrombosis Drug Production by Type
6.2 Global Arterial Thrombosis Drug Revenue by Type
6.3 Arterial Thrombosis Drug Price by Type

7 Arterial Thrombosis Drug Segment Market Analysis (by Application)
7.1 Global Arterial Thrombosis Drug Consumption by Application
7.2 Global Arterial Thrombosis Drug Consumption Market Share by Application (2014-2019)

8 Arterial Thrombosis Drug Major Manufacturers Analysis
8.1 Astellas Pharma Inc.
8.1.1 Astellas Pharma Inc. Arterial Thrombosis Drug Production Sites and Area Served
8.1.2 Astellas Pharma Inc. Product Introduction, Application and Specification
8.1.3 Astellas Pharma Inc. Arterial Thrombosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer AG
8.2.1 Bayer AG Arterial Thrombosis Drug Production Sites and Area Served
8.2.2 Bayer AG Product Introduction, Application and Specification
8.2.3 Bayer AG Arterial Thrombosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bristol-Myers Squibb Company
8.3.1 Bristol-Myers Squibb Company Arterial Thrombosis Drug Production Sites and Area Served
8.3.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.3.3 Bristol-Myers Squibb Company Arterial Thrombosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eisai
8.4.1 Eisai Arterial Thrombosis Drug Production Sites and Area Served
8.4.2 Eisai Product Introduction, Application and Specification
8.4.3 Eisai Arterial Thrombosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Arterial Thrombosis Drug Production Sites and Area Served
8.5.2 Johnson & Johnson Product Introduction, Application and Specification
8.5.3 Johnson & Johnson Arterial Thrombosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Sanofi
8.6.1 Sanofi Arterial Thrombosis Drug Production Sites and Area Served
8.6.2 Sanofi Product Introduction, Application and Specification
8.6.3 Sanofi Arterial Thrombosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Thromboserin Ltd
8.7.1 Thromboserin Ltd Arterial Thrombosis Drug Production Sites and Area Served
8.7.2 Thromboserin Ltd Product Introduction, Application and Specification
8.7.3 Thromboserin Ltd Arterial Thrombosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Arterial Thrombosis Drug Market
9.1 Global Arterial Thrombosis Drug Market Trend Analysis
9.1.1 Global Arterial Thrombosis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Arterial Thrombosis Drug Regional Market Trend
9.2.1 North America Arterial Thrombosis Drug Forecast 2019-2025
9.2.2 Europe Arterial Thrombosis Drug Forecast 2019-2025
9.2.3 China Arterial Thrombosis Drug Forecast 2019-2025
9.2.4 Japan Arterial Thrombosis Drug Forecast 2019-2025
9.2.5 Southeast Asia Arterial Thrombosis Drug Forecast 2019-2025
9.2.6 India Arterial Thrombosis Drug Forecast 2019-2025
9.3 Arterial Thrombosis Drug Market Trend (Product Type)
9.4 Arterial Thrombosis Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Arterial Thrombosis Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Arterial Thrombosis Drug
Table Global Arterial Thrombosis Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Arterial Thrombosis Drug Production Market Share by Types in 2018
Figure AS-1468240 Product Picture
Figure ASP-6537 Product Picture
Figure BAY-1213790 Product Picture
Figure BMS-65445 Product Picture
Figure Others Product Picture
Table Global Arterial Thrombosis Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Arterial Thrombosis Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Arterial Thrombosis Drug Revenue (Million USD) (2014-2025)
Figure Global Arterial Thrombosis Drug Production (K Pcs) (2014-2025)
Figure North America Arterial Thrombosis Drug Market Size (Million USD) (2014-2025)
Figure Europe Arterial Thrombosis Drug Market Size (Million USD) (2014-2025)
Figure China Arterial Thrombosis Drug Market Size (Million USD) (2014-2025)
Figure Japan Arterial Thrombosis Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Arterial Thrombosis Drug Market Size (Million USD) (2014-2025)
Figure India Arterial Thrombosis Drug Market Size (Million USD) (2014-2025)
Table Arterial Thrombosis Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Arterial Thrombosis Drug in 2018
Figure Manufacturing Process Analysis of Arterial Thrombosis Drug
Figure Industry Chain Structure of Arterial Thrombosis Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Arterial Thrombosis Drug Manufacturing Plants Distribution
Table Arterial Thrombosis Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Arterial Thrombosis Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Arterial Thrombosis Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Arterial Thrombosis Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Arterial Thrombosis Drug Production Share by Manufacturers in 2018
Table Arterial Thrombosis Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Arterial Thrombosis Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Arterial Thrombosis Drug Revenue Share by Manufacturers in 2018
Table Arterial Thrombosis Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Arterial Thrombosis Drug Production by Regions 2014-2019 (K Pcs)
Table Global Arterial Thrombosis Drug Production Market Share by Regions 2014-2019
Figure Global Arterial Thrombosis Drug Production Market Share by Regions in 2018
Table Global Arterial Thrombosis Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Arterial Thrombosis Drug Revenue Market Share by Regions 2014-2019
Figure Global Arterial Thrombosis Drug Revenue Market Share by Regions in 2018
Table Global Arterial Thrombosis Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Arterial Thrombosis Drug Consumption Market Share by Regions 2014-2019
Figure North America Arterial Thrombosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Arterial Thrombosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Arterial Thrombosis Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Arterial Thrombosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Arterial Thrombosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Arterial Thrombosis Drug Production, Consumption Import and Export (K Pcs)
Figure China Arterial Thrombosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Arterial Thrombosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Arterial Thrombosis Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Arterial Thrombosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Arterial Thrombosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Arterial Thrombosis Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Arterial Thrombosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Arterial Thrombosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Arterial Thrombosis Drug Production, Consumption Import and Export (K Pcs)
Figure India Arterial Thrombosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Arterial Thrombosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Arterial Thrombosis Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Arterial Thrombosis Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Arterial Thrombosis Drug Market Share by Application (2014-2019)
Table Astellas Pharma Inc. Arterial Thrombosis Drug Production Sites and Area Served
Table Astellas Pharma Inc. Arterial Thrombosis Drug Product Introduction, Application and Specification
Table Astellas Pharma Inc. Arterial Thrombosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astellas Pharma Inc. Arterial Thrombosis Drug Production Growth Rate (2014-2019)
Table Astellas Pharma Inc. Arterial Thrombosis Drug Production Market Share (2014-2019)
Figure Astellas Pharma Inc. Arterial Thrombosis Drug Revenue Market Share (2014-2019)
Table Astellas Pharma Inc. Arterial Thrombosis Drug Main Business and Markets Served
Table Bayer AG Arterial Thrombosis Drug Production Sites and Area Served
Table Bayer AG Arterial Thrombosis Drug Product Introduction, Application and Specification
Table Bayer AG Arterial Thrombosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Arterial Thrombosis Drug Production Growth Rate (2014-2019)
Table Bayer AG Arterial Thrombosis Drug Production Market Share (2014-2019)
Figure Bayer AG Arterial Thrombosis Drug Revenue Market Share (2014-2019)
Table Bayer AG Arterial Thrombosis Drug Main Business and Markets Served
Table Bristol-Myers Squibb Company Arterial Thrombosis Drug Production Sites and Area Served
Table Bristol-Myers Squibb Company Arterial Thrombosis Drug Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company Arterial Thrombosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Arterial Thrombosis Drug Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Arterial Thrombosis Drug Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company Arterial Thrombosis Drug Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company Arterial Thrombosis Drug Main Business and Markets Served
Table Eisai Arterial Thrombosis Drug Production Sites and Area Served
Table Eisai Arterial Thrombosis Drug Product Introduction, Application and Specification
Table Eisai Arterial Thrombosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Arterial Thrombosis Drug Production Growth Rate (2014-2019)
Table Eisai Arterial Thrombosis Drug Production Market Share (2014-2019)
Figure Eisai Arterial Thrombosis Drug Revenue Market Share (2014-2019)
Table Eisai Arterial Thrombosis Drug Main Business and Markets Served
Table Johnson & Johnson Arterial Thrombosis Drug Production Sites and Area Served
Table Johnson & Johnson Arterial Thrombosis Drug Product Introduction, Application and Specification
Table Johnson & Johnson Arterial Thrombosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Arterial Thrombosis Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Arterial Thrombosis Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Arterial Thrombosis Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Arterial Thrombosis Drug Main Business and Markets Served
Table Sanofi Arterial Thrombosis Drug Production Sites and Area Served
Table Sanofi Arterial Thrombosis Drug Product Introduction, Application and Specification
Table Sanofi Arterial Thrombosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi Arterial Thrombosis Drug Production Growth Rate (2014-2019)
Table Sanofi Arterial Thrombosis Drug Production Market Share (2014-2019)
Figure Sanofi Arterial Thrombosis Drug Revenue Market Share (2014-2019)
Table Sanofi Arterial Thrombosis Drug Main Business and Markets Served
Table Thromboserin Ltd Arterial Thrombosis Drug Production Sites and Area Served
Table Thromboserin Ltd Arterial Thrombosis Drug Product Introduction, Application and Specification
Table Thromboserin Ltd Arterial Thrombosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Thromboserin Ltd Arterial Thrombosis Drug Production Growth Rate (2014-2019)
Table Thromboserin Ltd Arterial Thrombosis Drug Production Market Share (2014-2019)
Figure Thromboserin Ltd Arterial Thrombosis Drug Revenue Market Share (2014-2019)
Table Thromboserin Ltd Arterial Thrombosis Drug Main Business and Markets Served
Figure Global Arterial Thrombosis Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Arterial Thrombosis Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Arterial Thrombosis Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Arterial Thrombosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Arterial Thrombosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Arterial Thrombosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Arterial Thrombosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Arterial Thrombosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Arterial Thrombosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Arterial Thrombosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Arterial Thrombosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Arterial Thrombosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Arterial Thrombosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Arterial Thrombosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Arterial Thrombosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Arterial Thrombosis Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Arterial Thrombosis Drug by Application (2019-2025)
Table Arterial Thrombosis Drug Distributors List
Table Arterial Thrombosis Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Astellas Pharma Inc.、Bayer AG、Bristol-Myers Squibb Company、Eisai、Johnson & Johnson、Sanofi、Thromboserin Ltd、

★調査レポート[世界の動脈血栓症薬市場 2019年] (コード：DATA909X03729)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の動脈血栓症薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の3D動脈スピンラベリング(3D ASL)市場 2019年
    DATA909X02697 / QYResearch / 2019年11月22日 / ※本調査レポートは、3D動脈スピンラベリング(3D ASL)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CASL、PASLに、用途別には、腫瘍、脳血管疾患、神経変性疾患、パーキンソン病にセグメント区分し、3D動脈スピンラベリング(3D ASL)の世界市場を分析しました。 ・エグゼクティブ・サマリー ・3D動脈スピンラベリング(3D ASL)の世界市場概要 ・3D動脈スピンラベリング(3D ASL)の製造コスト構成分析 ・3D動脈スピンラベリング(3D ASL)の開発・製造工場分析...The global 3D Arterial Spin Labeling (3D ASL) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 3D Arterial Spin Labeling (3D ASL) volume and value at global level, regional level and company level. From a global perspective, this report represents overall 3D Arterial Spin Labeling (3D ASL) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of 3D Arterial Spin Labeling (3D ASL) in North America, Europe, China,...
  • 世界の肺動脈高血圧症（PAH）治療薬市場 2019年
    DATA909X13888 / QYResearch / 2019年11月20日 / ※本調査レポートは、肺動脈高血圧症（PAH）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤に、用途別には、二次性肺高血圧症（SPH）、原発性肺高血圧症（PPH）にセグメント区分し、肺動脈高血圧症（PAH）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肺動脈高血圧症（PAH）治療薬の世界市場概要 ・肺動脈高血圧症（PAH）治療薬の製造コスト構成分析 ・肺動脈高血圧症（PAH）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肺動脈高血圧症（PAH）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肺動脈高血圧症（PAH）治療薬のセグメント分析（種類別） （エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤）...The global Pulmonary Arterial Hypertension (PAH) Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pulmonary Arterial Hypertension (PAH) Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pulmonary Arterial Hypertension (PAH) Medicine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pulmonary Arterial Hypertension (PAH) Medicine in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の勃起不全（ED）薬市場 2019年
    DATA909X07425 / QYResearch / 2019年11月15日 / ※本調査レポートは、勃起不全（ED）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、バルデナフィル、アバナフィル、タダラフィル、バルデナフィルに、用途別には、スーパーマーケット、オンラインストア、薬局、その他にセグメント区分し、勃起不全（ED）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・勃起不全（ED）薬の世界市場概要 ・勃起不全（ED）薬の製造コスト構成分析 ・勃起不全（ED）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・勃起不全（ED）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・勃起不全（ED）薬のセグメント分析（種類別） （バルデナフィル、アバナフィル、タダラフィル、バルデナフィル）...The global Erectile Dysfunction(ED) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Erectile Dysfunction(ED) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erectile Dysfunction(ED) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Erectile Dysfunction(ED) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のOTC薬市場 2019年
    DATA909X12465 / QYResearch / 2019年11月20日 / ※本調査レポートは、OTC薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クラスA、クラスBに、用途別には、病院、クリニック、家庭にセグメント区分し、OTC薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・OTC薬の世界市場概要 ・OTC薬の製造コスト構成分析 ・OTC薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・OTC薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・OTC薬のセグメント分析（種類別） （クラスA、クラスB）...The global OTC Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on OTC Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall OTC Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of OTC Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their OTC Drug manufacturing...
  • 世界の生体タンパク質薬市場 2019年
    DATA909X04601 / QYResearch / 2019年11月15日 / ※本調査レポートは、生体タンパク質薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、モノクローナル抗体、治療用タンパク質、ワクチンに、用途別には、製薬およびバイオテクノロジー企業、CRO、アカデミックにセグメント区分し、生体タンパク質薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・生体タンパク質薬の世界市場概要 ・生体タンパク質薬の製造コスト構成分析 ・生体タンパク質薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・生体タンパク質薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・生体タンパク質薬のセグメント分析（種類別） （モノクローナル抗体、治療用タンパク質、ワクチン）...The global Bio-protein Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Bio-protein Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-protein Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Bio-protein Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Bio-protein Drug manufacturing...
  • 世界のライノウイルス感染薬市場 2019年
    DATA909X14407 / QYResearch / 2019年11月20日 / ※本調査レポートは、ライノウイルス感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ライノウイルス感染薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ライノウイルス感染薬の世界市場概要 ・ライノウイルス感染薬の製造コスト構成分析 ・ライノウイルス感染薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ライノウイルス感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ライノウイルス感染薬のセグメント分析（種類別） （塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他）...The global Rhinovirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rhinovirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rhinovirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rhinovirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆